Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,513
Total Value
$93,005.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 9, 2026 | Exercise/Conversion | 2,171 | $16.00 | $34,736.00 | 84,660 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 9, 2026 | Sale | 2,171 | $26.84 | $58,269.64 | 82,489 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 9, 2026 | Exercise/Conversion | 2,171 | $0.00 | $0.00 | 23,876 | Direct | โ | View Details |